Funded Research

Single Channel analysis of the mechanism basis of Zn 2+ and H+ medical block of Kv1.5

Year

2001

Host institution

University of British Columbia

Research location

University of British Columbia – Point Grey

Partner

Supervisor

CO-lEad

A goal that scientists have long hoped for — the ability to design drugs based specifically on the known properties of their targets — motivated Daniel Kwan’s Masters research. In order to develop such target-specific drugs, the molecular structure of potential targets needs to be well-defined. Daniel contributed to this goal by combining techniques in electrophysiology, cell biology and molecular biology to study Kv1.5, a protein controlling the movement of potassium ions from heart muscle cells. The protein acts as a pathway for ions to pass through cell membranes. Results from the research show that zinc ions and protons can block these pathways by causing a reduction in the channels available. Daniel also examined how nickel ion affects these channels and results from this study point to a possible link between zinc and epileptic seizures. These findings could help in developing drugs to block the channels as a treatment for diseases such as irregular heartbeat and epilepsy

Building research careers

Since 2001, we’ve supported over 3,000 BC health researchers to launch programs, drive innovations, and attract millions in new research investment.

View all funded research

Funded research